A Phase 1 Study of Trametinib in Combination With Chemoradiation for KRAS Mutant Non-Small Cell Lung Cancer
Phase of Trial: Phase I
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Trametinib (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Pharmacokinetics
- 10 Jun 2017 Biomarkers information updated
- 10 Mar 2017 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2018.
- 15 Apr 2016 Status changed from suspended to recruiting.